Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy Siwicki, Marie; Gort-Freitas, Nicolas A; Messemaker, Marius; Bill, Ruben; ... Pittet, Mikaël 2021
add to browser selection
LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects Liao, Hsin-Wei; Garris, Christopher; Pfirschke, Christina; Rickelt, Steffen; ... Pittet, Mikaël 2019
add to browser selection
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy Rodell, Christopher B; Arlauckas, Sean P; Cuccarese, Michael F; Garris, Christopher S; ... Weissleder, Ralph 2018
add to browser selection
Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 Garris, Christopher S; Arlauckas, Sean P; Kohler, Rainer H; Trefny, Marcel P; ... Pittet, Mikaël 2018
add to browser selection
Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts Miller, Miles A; Chandra, Ravi; Cuccarese, Michael F; Pfirschke, Christina; ... Weissleder, Ralph 2017
add to browser selection
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H; Kitaoka, Maya; ... Pittet, Mikaël 2017
add to browser selection
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle Miller, Miles A; Gadde, Suresh; Pfirschke, Christina; Engblom, Camilla; ... Weissleder, Ralph 2015